Register for the Chainbreaker Cancer Fundraiser

Chainbreaker is a weekend experience of cycling, entertainment, and volunteerism with the core purpose of funding cancer research. We are committed to making Chainbreaker's annual cycling experience a place of honor, hope, optimism, determination, and change — driven by the passion of its riders, volunteers, and donors.

When is Chainbreaker?

Chainbreaker weekend is August 11-13th, 2017

Where does the money go?

100% of every dollar raised by riders, virtual riders and volunteers will go directly towards life-saving cancer research at the Masonic Cancer Center, University of Minnesota, a National Cancer Institute-designated comprehensive cancer center.

What are the bike routes?

Riders will depart out of Eagan from the Blue Cross Blue Shield campus. The route will take riders south and east through Rosemount, Farmington, and Hampton (25-mile finish with breakfast).  It will then connect with the beautiful Cannon Valley Trail out of Cannon Falls and head due east. The trail ends near Welch Village (50-mile finish with lunch/100 & 180-mile lunch) where the route will veer south and west passing through the small communities of Vasa, Belle Creek, Dennison, and Nerstrand, MN. Riders will continue west until they reach Cannon City.  This is where the route changes and heads north into Northfield and St. Olaf College (100-mile finish & 180-mile overnight). On Sunday, the 180-mile Riders will begin riding back in the direction of the Twin Cities. Safe to say the route will appeal to cyclists of all abilities!

What is the fundraising requirement?

Depending on which route you choose to ride, you will also have an accompanying fundraising commitment:

  • 25 miles - $1,000 minimum
  • 50 miles - $1,250 minimum
  • 100 miles - $1,750 minimum
  • 180 miles - $2,000 minimum

You have until 60 days after the ride to meet your fundraising commitment. The fundraising deadline is October 13, 2017

Register 

Share this post

Related News

  • Transplant Expert Becomes Transplant Minnesotan

    Andrew Adams, MD, PhD, has joined the Department of Surgery as a professor and as chief of the Division of Transplantation at both M Health Fairview University of Minnesota hospitals. He brings $11.7 million in funding from the National Institutes of Health focused on developing novel therapies to improve outcomes for transplant patients.

  • Study Analyzes if Telemedicine is Efficacious in Treating Opioid Use Disorder

    Federal and state agencies have temporarily allowed unprecedented flexibility for the use of telemedicine, including audio-only visits, for encounters where opioid use disorder (OUD) medications are prescribed. Cuong Pham, MD, an assistant professor in the Department of Medicine, is analyzing telemedicine’s efficacy for patients with OUD during COVID-19.

  • Researchers Study Cortisol Levels, Decision-Making in COVID-19 Healthcare Workers

    Alexander Herman, MD, PhD, in the Department of Psychiatry and Behavioral Sciences, and David Darrow, MD, MPH, in the Department of Neurosurgery, are studying hair samples from frontline healthcare workers during the COVID-19 pandemic to determine how their cortisol levels might correlate with their responses on a multi-armed bandit task.”